e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Lung function and therapy in obstructive lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled and nasal NO levels in patients with primary cilliary dyskinesia (PCD)
J. Pawlik, W. Tomalak, W. Myszkal, J. Radlinski (Rabka, Poland)
Source:
Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Session:
Lung function and therapy in obstructive lung diseases
Session type:
Electronic Poster Discussion
Number:
4370
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Pawlik, W. Tomalak, W. Myszkal, J. Radlinski (Rabka, Poland). Exhaled and nasal NO levels in patients with primary cilliary dyskinesia (PCD). Eur Respir J 2007; 30: Suppl. 51, 4370
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Knowing asthma in adolescentes from Uruguaiana: The Global Asthma Network (GAN)
Primary ciliary dyskinesia and non-CF bronchiectasis
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia
Related content which might interest you:
New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals.
Source: International Congress 2017 – Primary ciliary dyskinesia and air pollution
Year: 2017
Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 623s
Year: 2005
Eicosanoids in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia
Source: Eur Respir J 2003; 21: 43-47
Year: 2003
Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia
Source: Eur Respir J 2004; 24 : 881-883
Year: 2004
Upper and lower airway nitric oxide levels in primary ciliary dyskinesia
Source: Annual Congress 2012 - New understanding of childhood lung disease through physiological measurement
Year: 2012
Nitric oxide metabolites in exhaled breath condensate of children with primary ciliary dyskinesia
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Nasal cavity inflammation in patients with primary ciliary dyskinesia (PCD) is associated with bacterial infection
Source: International Congress 2017 – Paediatric respiratory infections and immunity
Year: 2017
Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia (PCD)
Source: Annual Congress 2004 - Chronic respiratory illness in childhood
Year: 2004
Nasal nitric oxide measurement in 39 children consecutively referred for primary ciliary dyskinesia work up
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007
Nitric oxide biosynthesis by primary ciliary dyskinesia respiratory epithelial cells is similar to non-PCD patients
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Exhaled NO levels in patients with chronic cough in Japan
Source: Eur Respir J 2006; 28: Suppl. 50, 671s
Year: 2006
Nasal nitric oxide (nNO) in paediatric primary ciliary dyskinesia (PCD) and in healthy children - On the lookout for optimal cut-off and reference range
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia
Source: Eur Respir J 2011; 37: 559-565
Year: 2011
Ciliary dyskinesias: primary ciliary dyskinesia in adults
Source: Eur Respir Mon 2011; 52: 130-149
Year: 2011
Lack of nasal nitric oxide increase by humming in primary ciliary dyskinesia
Source: Annual Congress 2003 - Advances in paediatric respiratory physiology
Year: 2003
Relevance of nasal nitric oxide measurements using tidal breathing method for screening primary ciliary dyskinesia in young children
Source: Virtual Congress 2020 – Respiratory physiology and sleep: new approaches to diagnosis and treatment
Year: 2020
Alveolar but not airway fractional exhaled nitric oxide concentration (FENO) is decreased in obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 467s
Year: 2003
The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FE
NO
) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept